GeekWire |
Alpine Immune Sciences raising $17M in advance of merger with Colorado pharmaceutical company
GeekWire Seattle biotech company Alpine Immune Sciences is raising $17 million as part of a merger with Nivalis, a publicly-traded pharmaceutical firm in Boulder, Colo. Frazier Healthcare Partners, Alpine BioVentures, and OrbiMed Advisors will invest the cash … Former Dendreon CEO debuts new public company in reverse mergerBioPharma Dive Alpine Immune Sciences gets cash, stock listing in biotech merger …The Seattle Times Nivalis Therapeutics (NVLS) Stock: Gaining On Merger NewsCNA Finance (press release) TheStreet.com all 27 news articles » |
April 20, 2017 at 06:04AM
from Google Inc.
No comments:
Post a Comment